Fresenius SE & Co. KGaA (LON:0OO9)

London flag London · Delayed Price · Currency is GBP · Price in EUR
48.76
+0.25 (0.52%)
At close: Dec 23, 2025
47.95%
Market Cap23.99B
Revenue (ttm)19.59B
Net Income (ttm)997.68M
Shares Outn/a
EPS (ttm)1.77
PE Ratio24.04
Forward PE13.34
Dividend0.84 (1.72%)
Ex-Dividend DateMay 26, 2025
Volume1,389
Average Volume138,737
Open48.71
Previous Close48.51
Day's Range48.31 - 48.79
52-Week Range31.99 - 50.74
Beta0.92
RSI56.33
Earnings DateMar 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 176,486
Stock Exchange London Stock Exchange
Ticker Symbol 0OO9
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.